This comprehensive review discusses clinical studies of patients following brain injuries (traumatic, acquired, or stroke), who have been treated with amantadine or memantine
The antiparkinsonian drugs amantadine, bromocriptine, and levodopa combined with carbidopa (e
trouble sleeping
Disorders of consciousness, including the coma state, vegetative state and minimally conscious state, are among the least understood and least curable conditions in modern neurology
amantadine treatment was numerically higher in the amantadine group (amantadine: 10
Conclusions Amantadine treatment is associated with improved consciousness among patients with different types of non-traumatic brain injury in this observational Patients were randomized to either receive amantadine (87) or visually identical placebo (97) over the 4-week study interval
Extended-release capsules: Initial dose: 137 mg orally once a day at bedtime
Canadian Journal of Neurological Sciences
It is used to treat Parkinson's disease (sometimes called "paralysis agitans" or "shaking palsy") and its symptoms, including dyskinesia (sudden uncontrolled movements)
The actual incidence (although quite We would like to show you a description here but the site won’t allow us
Its molecular weight is 187
loss of memory
It's used to treat symptoms of movement disorders in adults, including Parkinson’s disease (PD)
In recent years, amantadine has also been found to be useful for some in reducing dyskinesias (involuntary movements) that occur with dopamine medication